IGF1R and nasopharyngeal carcinoma: YTHDC2 physically binds to insulin-like growth factor 1 receptor (IGF1R) mRNA to promote the translation of IGF1R mRNA, which in turn activates the IGF1-AKT/S6 signaling pathway and promotes radiotherapy resistance in nasopharyngeal carcinoma cells [301].